Alerts:  Feb. 21: Some federal websites are experiencing disruptions while being reviewed for compliance with President Trump’s executive orders. As a result, some links and information on srhd.org may be unavailable.

Measles Alert for Health Care Providers

Contact Us

Measles Case Confirmed in Seattle Area with Public Exposures and Measles Outbreak in Texas

Posted March 5, 2025. Past health advisories and alerts are archived for historical purposes and are not maintained or updated.

Public Health Seattle King County has identified one confirmed cases of measles (rubeola) in an infant who was exposed to the measles virus while traveling outside the United States. The case was present at the following locations and dates during the infectious period:

DateTimeLocation

2/20/25

6-9 p.m.

Apple Store at Bellevue Square
213 Bellevue Square, Bellevue, WA 98004

2/21/25 – 2/22/25

10:30 p.m.-2:15 a.m.

Seattle Children’s Hospital Emergency Department
4800 Sand Point Way NE, Seattle, WA 98105

2/24/25

1-4:15 pm

Allegro Pediatrics – Bothell
11724 NE 195th St., Ste. 100, Bothell, WA 98011

2/25/25

1-4:00 p.m.

Northwest Asthma & Allergy Center
8301 161st Ave. NE, Ste. 308, Redmond, WA 98052

2/25/25

2:30-5:30 p.m.

Seattle Children’s Hospital Emergency Department
4800 Sand Point Way NE, Seattle, WA 98105

Whenever possible, contacts of a measles case are notified of their exposure. However, in public exposure settings it is not possible to determine all who may have been exposed.

If susceptible persons were exposed to this individual at the public locations identified, we would expect to see resultant cases become ill between 2/27/2025 through 3/18/2025.

At this time, we are not aware of additional cases in Washington, however, we urge your office to be prepared for handling potential cases of measles. If additional exposure sites/times become known, we will list them on For Healthcare Providers | SRHD under the Advisories & Alerts section.

Measles Outbreak in Texas

As of March 4, 2025, the measles outbreak in Texas has grown to 159 cases, 22 of whom have been hospitalized. There has been one death in an unvaccinated school-aged child who lived in the outbreak area. Visit this link for the most recent updates: News & Alerts | Texas DSHS

Requested Actions

Please be aware of this case and the measles outbreaks happening within the US and internationally when patients present with symptoms consistent with measles.

Use the Measles Quick Assessment for Providers (srhd.org) form to evaluate symptoms and for guidance on collecting and submitting specimens.

Report suspect measles cases immediately to SRHD Epidemiology:

  • Please do not delay reporting suspected measles cases to SRHD while awaiting laboratory confirmation. Control measures are most effective if public health is able to contact those exposed within 72 hours of exposure. If you have any concern about measles in your patient, contact SRHD immediately.
  • Communicable Disease Epidemiology: 509.324.1442 (during business hours)
  • Urgent and Emergency Needs (24/7 Duty Officer): 509.869.3133

We will consult with you regarding testing and specimen collection to determine if they meet criteria for testing at the WA State Public Health Laboratory.

Recognizing a Potential Case of Measles

Measles is a viral illness consisting of fever, cough, coryza, conjunctivitis (the “three Cs”), maculopapular rash, and Koplik spots. Usually, cold symptoms and fever precede the onset of the rash by two to four days, and a measles case will often feel ill enough to seek medical care BEFORE rash onset. If a patient has presented with coryza, light sensitivity, or cough with high fever and has a possible history of having been present at one of the locations mentioned above, please consider measles a possibility and notify SRHD immediately. The red rash usually begins on the face and spreads to the rest of the body. Koplik spots appear inside the mouth on the buccal mucosa and look like grains of sand (absence of Koplik spots does not rule out measles).

Ideally, a suspect measles case should bypass other patient waiting areas. Alert your reception staff on how to identify and isolate patients who present with these symptoms. Complications of measles can include otitis media, bronchopneumonia, laryngotracheobronchitis, diarrhea, and encephalitis.

Infection Prevention

Measles primarily spreads through large droplets but can also be transmitted through the airborne route. The virus can be transmitted through the latter route up to two hours after a contagious patient coughed or sneezed, according to the Centers for Disease Control and Prevention (CDC).

Preventing health care exposures is critical to keep high risk groups safe.

  • When possible, use phone triage and assessment to determine if patients who might have measles need to be seen in-person.
  • Up-to-date vaccination status makes measles much less likely.
  • Healthcare personnel (HCP) without acceptable presumptive evidence of measles immunity should not enter a known or suspected measles patient’s room if other HCP with presumptive evidence of immunity are available.

Please implement interventions listed below in your clinical settings to minimize exposure to others.

  • If the patient is already in the clinic/waiting room, room them immediately and place on airborne precautions.
  • Use a negative pressure room if available; regardless, keep exam room door closed.
  • Perform all labs and clinical interventions in the exam room if possible.
  • The exam room should not be used for two hours after the patient has left.
  • Patients who are under evaluation for measles should isolate at home until the diagnosis is clarified.

Post-Exposure Prophylaxis of Close Contacts

To potentially provide protection or modify the clinical course of disease among susceptible persons, either administer MMR vaccine within 72 hours of initial measles exposure, or immunoglobulin (IG) within six days of exposure. Do not administer MMR vaccine and IG simultaneously, as this practice invalidates the vaccine.

Individuals who should receive immunoglobulin (IG) due to severe disease and complications include:

  • Infants <12 months of age
    Infants 6-11 months of age can receive MMR vaccine in place of IG, if administered within 72 hours of exposure.
  • Pregnant women without evidence of measles immunity
  • Severely immunocompromised persons regardless of vaccination status.
  • IG can be given to others who do not have evidence of measles immunity, however, those with intense, prolonged, close contact exposure should be prioritized.

Immunization Guidance & Local Coverage Rate Information

Measles, mumps, rubella (MMR) vaccine is a two-dose series routinely recommended for children to be administered at 12-15 months of age and 4-6 years of age.

  • Children can receive the second dose earlier if it is at least 28 days after the first dose.
  • There are no single antigen vaccine options available in the U.S.; a measles vaccine is only available in the combination presentations described below.
  • Two MMR vaccines are available for use in the United States, M-M-R II and PRIORIX. M-M-R II and PRIORIX are fully interchangeable for all indications for which MMR vaccination is recommended.
  • Children may also receive the MMR/V vaccine, which protects against measles, mumps, rubella, and varicella (chickenpox). The MMR/V vaccine is indicated for children who are 12 months through 12 years of age.

MMR vaccination is also recommended for adults if born in 1957 or later.

  • Immunocompetent adults need one dose of MMR vaccine.
  • Immunocompromised adults need 2 doses at least 28 days apart.
    You can view specific details on immunocompromising conditions under measles, mumps, and rubella vaccination: special situations here: Adult Immunization Schedule Notes
  • Persons who were vaccinated with an inactivated vaccine that was available from 1963-1967 and have not been re-vaccinated may be at risk for measles.

Current coverage rates in Spokane County are below the recommended herd immunity threshold of 92-94%. According to the Washington State Immunization Information System (WA IIS), as of December 27, 2024:

  • 86% of children 19-35 months old have received their first dose of MMR vaccine.
  • 70% of children ages 4-6 years have received their second dose of MMR.

Reminder/Recall Strategy

Reminder/Recall is a strategy used to identify patients who are due or overdue for vaccines. This strategy helps keep your patients up to date with recommended vaccines and can help mitigate the impact of community outbreaks. Spokane Regional Health District is recommending that all providers utilize this strategy to reach out to patients who are not up to date with their MMR vaccines.

Many electronic medical record (EMR) systems can generate a report of patients who are due or overdue for vaccinations. If your EMR doesn’t have this ability, you can utilize the WA IIS to perform a reminder/recall. Washington Department of Health (DOH) has a reference guide available on how to run this report.

MyIR Mobile

DOH has created a web-based application for the public to access their immunization records in the Washington immunization registry. Patients can access this site as a strategy to reduce the number of requests for immunization records. Patients can sign-up for MyIR Mobile at myirmobile.com to view immunization records for themselves and their family members.

Resources